Status | Study |
Withdrawn |
Study Name: Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer Condition: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcino Date: 2012-10-29 Interventions: Drug: photodynamic therapy Und |
Terminated |
Study Name: Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Metast Date: 2012-02-03 Interventions: Biological: talactoferrin Give |
Active, not recruiting |
Study Name: Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High-Risk Appalachian Patients Previously Treated With Surgery For Oral Cancer Condition: Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity Stage I Squamous Cell Carcinoma o Date: 2011-12-15 Interventions: Drug: lyophilized black raspberry lozenge |
Recruiting |
Study Name: Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck Condition: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Mucoepidermoid Carcinoma of Date: 2011-11-07 Interventions: Procedure: transoral robotic surgery |
Recruiting |
Study Name: Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions Condition: Lip and Oral Cavity Squamous Cell Carcinoma Oral Cavity Verrucous Carc Date: 2011-08-09 Interventions: Drug: vandetanib Given PO |
Completed |
Study Name: TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Recurrent Metast Date: 2011-03-21 Interventions: Drug: TLR8 agonist VTX-2337 Gi |
Terminated |
Study Name: Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC Condition: Salivary Gland Squamous Cell Carcinoma Stage II Salivary Gland Cancer Date: 2011-01-24 Interventions: Radiation: intensity-modulated radiation therapy |
Completed |
Study Name: Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy Condition: Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Date: 2010-12-07 Interventions: Biological: Cetuximab Given IV |
Active, not recruiting |
Study Name: Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer Condition: Recurrent Colon Carcinoma Recurrent Hypopharyngeal Squamous Cell Carcinoma Date: 2010-12-03 Interventions: Biological: Cetuximab Given IV |
Terminated |
Study Name: Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer Condition: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Recurrent Lymphoepithelioma of the Nas Date: 2010-11-03 Interventions: Procedure: transoral robotic surgery |